-

Nomi Health’s Baltimore Clinic Moves to New Location

Nomi Health will continue to offer Mpox vaccinations In partnership with the Baltimore City Health Department at its new location.

--(BUSINESS WIRE)--Nomi Health:

WHO/WHAT: Nomi Health, the direct healthcare company making it easy to access high-quality affordable care across the U.S., is moving its clinic to a new location. In addition to offering Mpox (monkeypox) vaccinations in partnership with the Baltimore City Health Department, the clinic will continue to provide Antigen, PCR and Rapid PCR Covid testing.

Appointments may be made here for Covid testing.

Appointments for both first and second doses of the Mpox vaccination may be made here. The clinic will also accept walk-in patients.

WHEN:

Tuesday, February 28, 2023.

 

WHERE:

Nomi Health Baltimore clinic,

10 West Eager Street, Ste 215

Baltimore, MD 21201

 

Clinic Hours for Covid testing are:

8:00 a.m. - 5:00 p.m. Monday - Saturday

8:00 a.m. - 3:00 p.m. Sunday

 

Clinic hours for Mpox vaccinations are:

8:00 a.m. - 5:00 p.m., Monday, Tuesday, Thursday, Friday and Saturday

10:00 a.m. - 7:00 p.m. Wednesday

ADDITIONAL INFORMATION: To review eligibility requirements for Mpox vaccinations, visit the Baltimore City Health Department website here.

About Nomi Health

Nomi Health is a nationwide direct healthcare system making it easier than ever for any buyer of healthcare to access the highest quality affordable care for their communities. The company’s direct care ecosystem encompasses a real-time operating and payment platform— inclusive of analytics and payment infrastructure— as well as an integrated care delivery architecture featuring essential care services, pharmacy, and an open network. To date, Nomi Health has saved buyers of care an average of 30 percent compared to traditional healthcare costs, while enabling them to give their communities more access to lower-cost, high-quality care.

Based in Orem, Utah, Nomi Health employs more than 2,000 nationwide, working to lower healthcare expenses, widen care access and improve the patient experience. The company is led by an experienced, cross-functional leadership team with clinical, healthcare, technology, and finance backgrounds. Nomi Health has so far invested more than $10 million dollars in improving the well-being of the communities it serves. Visit us on Twitter @NomiHealth and www.nomihealth.com.

Contacts

Maggie Habib
310.916.6934 direct
maggie.habib@nomihealth.com

Nomi Health


Release Versions

Contacts

Maggie Habib
310.916.6934 direct
maggie.habib@nomihealth.com

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom